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Abstract
Background: Select hair products contain endocrine disrupting chemicals (EDCs) that may affect breast cancer risk.
We hypothesize that, if EDCs are related to breast cancer risk, then they may also affect two important breast
cancer risk factors: age at menarche and mammographic breast density.
Methods: In two urban female cohorts (N = 248): 1) the New York site of the National Collaborative Perinatal Project
and 2) the New York City Multiethnic Breast Cancer Project, we measured childhood and adult use of hair oils, lotions,
leave-in conditioners, root stimulators, perms/relaxers, and hair dyes using the same validated questionnaire. We
used multivariable relative risk regression models to examine the association between childhood hair product use
and early age at menarche (defined as <11 years of age) and multivariable linear regression models to examine the
association between childhood and adult hair product use and adult mammographic breast density.
Results: Early menarche was associated with ever use of childhood hair products (RR 2.3, 95% CI 1.1, 4.8) and hair
oil use (RR 2.5, 95% CI 1.2, 5.2); however, additional adjustment for race/ethnicity, attenuated associations (hair
products RR 1.8, 95% CI 0.8, 4.1; hair oil use RR 2.3, 95% CI 1.0, 5.5). Breast density was not associated with adult or
childhood hair product or hair oil use.
Conclusions: If confirmed in larger prospective studies, these data suggest that exposure to EDCs through hair
products in early life may affect breast cancer risk by altering timing of menarche, and may operate through a
mechanism distinct from breast density.
Keywords: Menarche, Mammographic breast density, Endocrine disrupting chemicals, Cosmetics
Background
Recent trends suggest a convergence in the incidence of
breast cancer rates in black and white women due to the
stability in incidence trends in white women compared
to the steady annual increase in black women (0.3% per
year) [1, 2]. These changing incidence patterns over a
short time period cannot be attributed to changing gen-
etic factors. As such, it is important to consider the role
of environmental exposures that may differ in black and
white women. Given that breast cancer risk may be most
influenced when the breast changes in structure and
function, consideration of environmental exposures dur-
ing critical and sensitive windows of susceptibility is es-
sential for providing evidence on new risk factors.
Endocrine disrupting chemicals (EDCs) have been pos-
ited as potential environmental factors that could affect
breast cancer risk through their ability to have direct ac-
tion on hormone receptors; interference with transport
or feedback; behave as agonist or antagonist of nuclear
receptors; or confer epigenetic changes that increase
oncogenic susceptibility [3–5]. Of particular concern,
EDCs may be more deleterious when the breast tissue is
highly proliferative, such as during puberty [6]. Clinical,
epidemiological, and laboratory studies have suggested
EDCs are associated with earlier pubertal events [6] and
timing of pubertal maturation is associated with breast
cancer risk [7]. For every 1-year delay in menarche, the
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risk of breast cancer decreases by around 5% [8, 9]. Fur-
ther, certain EDCs are important breast carcinogens that
may impact breast tissue remodeling, which in turn may
affect mammographic breast density [10], a measure of
the amount of fibroglandular breast tissue and one of
the strongest risk factors for breast cancer [11–13].
Hair products that contain estrogens or xenoestrogens
may interfere with the normal activity of the endocrine
system through hormonal dysregulation [4]. Natural and
synthetic EDCs are added to hair products to encourage
hair growth (estrogen), provide scent (phthalates), and
for product preservation (parabens) [3, 14]. Women and
certain racial/ethnic minorities tend to be frequent and
long-term users of such products, which are applied dir-
ectly to the hair and scalp [3, 15, 16]. The Black
Women’s Health Study surveyed African American
women and found that 94% under age 45 and 89% over
age 45 use perms or relaxers [17]. The Women’s Circle of
Health Study corroborates findings, reporting 87% of
African American women, but 6% of European Ameri-
can women have a history of regularly using chemical
relaxers [18]. Moreover, in the Greater New York Hair
Products Study, of 16 specific brands of hair products
that were identified as commonly used among the par-
ticipants, 69% of the products contained parabens [15].
This routine and chronic use of products containing
EDCs may impact breast cancer; however, few studies
have evaluated hair product use and breast cancer risk
factors [19, 20].
To address this gap, we examine the association of
hair product use with two important breast cancer risk
factors - age at menarche and mammographic breast
density. We hypothesize that the use of hair products
in childhood is associated with earlier age at menar-
che and hair product use in childhood and adulthood
may be associated with greater mammographic breast
density.
Methods
We used data from an adult follow-up study of the New
York site of the National Collaborative Perinatal Project
(hereafter referred to as NY-NCPP) that included
women born between 1959 and 1963 and followed up
between 2001 and 2006 (for details see [21–24]). We
also used data from the New York City Multiethnic
Breast Cancer Project (hereafter referred to as NY-
MBCP), which recruited women between the ages of 40
and 60 years from 2007 to 2008 (for details see [25, 26]).
The two studies followed similar protocols and used the
same validated questions on hair product use and also
the same methods for assessing mammographic breast
density. We collected information on hair product use
and mammograms from subsets of these cohorts; the
final combined sample included 248 women (98 from
NY-NCPP and 150 from NY-MBCP). The Internal
Review Boards at Columbia University, Long Island
University, and Long Island College Hospital in Brooklyn
approved these studies.
Study participants were asked to complete questions on
hair product use in childhood (before age 13) and adult-
hood (since age 20); specifically ever use of hair oils, lo-
tions, leave-in conditioners, root stimulators, perms/
relaxers, and hair dyes as previously described [19]. Hair
product use was defined in three ways for each time
period: 1) ever use of any category of hair product (re-
ferred to as ever use), 2) ever use of hair oils (referred to
as hair oils), 3) ever use of any other category of hair care
product (excluding hair oils; referred to as other products)
[15, 19]. For the latter category, we collapsed hair lotions,
leave-in conditioners, root stimulators, perms/relaxers,
and hair dyes into this category due to too few participants
reporting use [19]. We defined the childhood ever use ex-
posure variables as ever using hair products before age 13.
We calculated the duration of childhood use of hair oils
based on the assumption that, once a woman reported the
use of hair oils, she would continue to use them until age
13. Therefore, we calculated duration based on the age
women reported they started using hair oils up until age
13. For women who reported their age at menarche occur-
ring before age 11, their childhood hair product exposure
occurred prior to menarche. In other words, among
women who reported experiencing menarche before age
11, all had hair product use before age 11. We defined
adult ever use exposure variables as ever using hair prod-
ucts at or after age 20. We calculated the duration of adult
use of hair oils as the difference between the time of first
use at age 20 or older and the woman’s age at interview or
when she reported stopping product use.
We examined two breast cancer risk factors: age at
menarche and mammographic breast density. Age at
menarche was self-reported by participants (for details
see [23, 25]). In both studies, mammograms were only
requested if the woman already received a screening
mammogram. For NY-NCPP, among all available mam-
mograms, we used the mammogram taken closest to the
interview data collection. The majority of mammograms
for the NY-MBCP projects were obtained on the same
day as the interviews that collected hair product use and
other covariate data. Details on mammographic density
assessment have been described previously for NY-
NCPP [24] and for NY-MBCP [25]. We excluded women
who had a history of breast cancer. Briefly, we measured
dense breast area and total breast area (measured in
pixels and converted to cm2), and calculated percent
density as total dense area divided by total breast area,
multiplied by 100. Pearson correlation of reader reliabil-
ity for both studies ranged from 0.87–0.99 for breast
area and 0.90–0.93 for dense area.
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For covariates, we collected sociodemographic data
(age, education, and race/ethnicity) and health informa-
tion (self-reported height and weight) through a ques-
tionnaire. Race/ethnicity was based on adult self-report
as described previously [25–27]. We categorized race
and ethnicity as Hispanic, non-Hispanic black, and non-
Hispanic white. For our analyses, we included women
who had complete information on hair product use in
childhood and adulthood (n = 98 from NY-NCPP and n =
150 from NY-MBCP).
After descriptive analyses, we used multivariable rela-
tive risk regression using the binomial link to examine
the association between childhood hair product use and
the age at menarche (<11 years compared to ≥11 years
(referent)). We also conducted a sensitivity analysis
modeling age at menarche as a continuous variable using
linear regression. Additionally, we conducted sensitivity
analyses to determine if the association between early
life exposure of hair product use and age at menarche
had a stronger effect in younger women (independently
defined as under age 50 or not postmenopausal). We
also used logistic regression to model duration of child-
hood hair oil use and the age at menarche when ad-
justed for age at interview and site only. Additionally, we
adjusted for race/ethnicity. However, the additional ad-
justment for race/ethnicity could lead to structural con-
founding due to minimal overlap between racial/ethnic
groups with respect to hair product use. As such, models
adjusted for race/ethnicity should be interpreted with
caution. We assessed age at interview, cohort, and race/
ethnicity as potential confounders and included them in
the final model, if they altered the association between
childhood hair product use and age at menarche by
more than 10% in the multivariable models. To deter-
mine the association between hair product use and
mammographic breast density (percent density and total
dense area), we performed linear regression. We log
transformed the mammographic breast density measures
for the regression analyses. We also modeled duration of
adult hair oil use and mammographic breast density
measures when adjusted for age at interview, BMI, site,
and race/ethnicity. We assessed age at interview, cohort,
adult BMI, and race/ethnicity as potential confounders
and included them in the model if they altered the asso-
ciation between adult hair product use and mammo-
graphic breast density measures by more than 10% in
the multivariable models. Again, structural confounding
for models adjusted for race/ethnicity could be a potential
issue and should be interpreted with caution. As such,
models with and without adjustment for race/ethnicity are
presented. For all analyses, we modeled exposure of hair
product use and duration as defined above. We performed
all analyses in the combined sample of both cohorts, and
stratified by cohort membership.
Results
Table 1 details the differences between epidemiologic
factors, breast cancer risk factors, and the use of hair
products by cohort. We found that childhood ever
use of any hair product and childhood ever use of
hair oil were associated with a higher probability of
reaching menarche before 11 years of age (Table 2).
We also observed a non-significant, positive associ-
ation between menarche before age 11 and ever use
of other hair products in childhood (Table 2). After
adjusting for race/ethnicity, the associations were dir-
ectionally similar, though non-significant (childhood
any hair product use RR 1.8, 95% CI 0.8, 4.1; hair oil
RR 2.3, 95% CI 1.0, 5.5; and other products RR 1.5,
95% CI 0.7, 3.2). When stratified by race/ethnicity, we
found the association between childhood hair oil ever use
and menarche were directionally similar, though non-
significant, in Hispanic (RR 2.91, 95% CI 0.9, 9.2) and
non-Hispanic black women (RR 1.8, 95% CI 0.6, 5.3).
There were no non-Hispanic white women that reported
using hair products before age 11 years. Given the cat-
egorical outcome, we had low power to look at associa-
tions by the cohorts separately. However, we did observe
cohort-specific associations between childhood hair prod-
uct use and age at menarche before 11 years of age were
in the same direction as our overall findings (data not
shown).
In the sensitivity analysis of hair product use and age
at menarche, where menarche was modeled continu-
ously, we observed a non-significant inverse relationship,
suggesting childhood hair product use was associated
with earlier age at menarche (childhood any hair product
use β -0.3, 95% CI -0.8, 0.1; hair oil β -0.2, 95% CI -0.7,
0.2; and other products β -0.3, 95% CI -0.9, 0.2). In an
additional sensitivity analysis where we adjusted for age
at interview and cohort, associations between childhood
hair product use (ever use, hair oil use, and other use)
and categorical age at menarche (i.e. before age 11 v. at
or after age 11 years) were stronger when we limited
analyses to women under 50 years of age (all models P
< 0.05) or restricted to those who were not postmeno-
pausal (all models P < 0.05). In these latter sensitivity
analyses, sample size restricted our ability to adjust for
race/ethnicity, as only non-Hispanic black women
remained in the models when restricting to younger
women (data not shown).
There was no association between childhood hair
product use and mammographic breast density mea-
sures (Table 3). There was a statistically significant
association between other adult hair product use and
mammographic percent density and dense area after
adjusting for age at interview, BMI, and cohort
(Table 3). Estimates did not change with additional
adjustment for race/ethnicity (data not shown). Upon
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Table 1 Distribution of epidemiologic factors, breast cancer risk factors, and hair product use in the New York National Collaborative
Perinatal Project (NY-NCPP) and the New York City Multiethnic Breast Cancer Project (NY-MBCP)
Overall (N = 248) NY-NCPP (N = 98) NY-MBCP (N = 150)
Mean ± SD or N (%) Mean ± SD or N (%) Mean ± SD or N (%)
Sociodemographic factors
Age (years) 46.8 ± 5.9 42.0 ± 1.8 49.9 ± 5.5*
Race/Ethnicity
Hispanic 60 (24.2) 37 (37.8) 23 (15.3)
non-Hispanic black 123 (49.6) 33 (33.7) 90 (60.0)*
non-Hispanic white 65 (26.2) 28 (28.6) 37 (24.7)
Education
High school or less 52 (21.1) 11 (11.2) 41 (27.5)*
Some college 84 (34.0) 37 (37.8) 47 (31.5)
College or more 11 (44.9) 50 (51.0) 61 (40.9)
Breast Cancer Risk Factors
Body Mass Index (kg/m2) 29.0 ± 6.9 27.8 ± 6.8 29.8 ± 6.9*
Body Mass Index (kg/m2)
< 25 77 (32.1) 37 (39.4) 40 (27.4)
≥ 25 163 (67.9) 57 (60.6) 106 (72.6)
Breast Percent Density (%) 15.4 ± 12.5 18.9 ± 13.3 13.1 ± 11.4*
Breast Dense Area (cm2) 20.0 ± 16.1 23.7 ± 17.9 17.5 ± 14.4*
Age at menarche 12.4 ± 1.7 12.5 ± 1.6 12.3 ± 1.7
Age at menarche
< 11 years 26 (11.3) 7 (8.9) 19 (12.7)
≥11 years 203 (88.7) 72 (91.1) 131 (87.3)
Menopausal status
Pre/Peri-menopausal 176 (75.5) 79 (95.2) 97 (64.7)*
Postmenopausal 57 (24.5) 4 (4.8) 53 (35.3)
Childhood Use of Hair Products (ever use) 106 (42.7) 35 (35.7) 71 (47.3)
Hair oils 92 (37.1) 29 (29.6) 63 (42.0)
Hair lotions 24 (9.7) 13 (13.4) 11 (7.3)*
Root stimulators 3 (1.2) – 3 (2.0)
Leave-in conditioners 20 (8.1) 12 (12.2) 8 (5.3)
Perms/relaxers 15 (6.1) 9 (9.2) 6 (4.0)
Hair dyes 2 (0.8) – 2 (1.3)
Overall duration of childhood use of hair oil (years) 7.8 ± 3.1 7.7 ± 3.1 7.8 ± 3.2
Adult Use of Hair Products (ever use) 229 (92.3) 85 (86.7) 144 (96.0)*
Hair oils 117 (47.2) 33 (33.7) 84 (56.0)*
Hair lotions 109 (44.0) 31 (31.6) 78 (52.0)*
Root stimulators 38 (15.3) 9 (9.2) 29 (19.3)*
Leave-in conditioners 140 (56.5) 54 (55.1) 86 (57.3)
Perms/relaxers 153 (61.7) 53 (54.1) 100 (66.7)*
Hair dyes 153 (61.7) 60 (61.2) 93 (62.0)
Overall duration of adult use of hair oil (years) 25.4 ± 7.1 21.4 ± 3.3 26.9 ± 7.7*
*p < 0.05; represents the test for differences between cohorts
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examination of individual hair products, adult hair
dye use was associated with a slight increase in per-
cent mammographic density (β 0.4, 95% CI 0.1, 0.6)
and dense area (β 0.3, 95% CI 0.03, 0.5). Findings
were similar when limited to women under age 50.
After adjusting for confounders, there were no associa-
tions between duration of hair oil use in childhood and
age at menarche (RR 1.0, 95% CI 0.8, 1.3) or between the
duration of hair oil use in adulthood and mammographic
breast density (percent density β 0.02, 95% CI -0.01, 0.05;
dense area β 0.02, 95% CI -0.01, 0.05).
Discussion
In the present study, we found that childhood hair product
use was associated with earlier age at menarche, which is
consistent with the existing literature [16, 19, 20]. Tiwary
and colleagues were among the first to observe the use of
topical applications of hair products during childhood in
Table 2 Binomial regression of childhood hair product use and age at menarche (<11 vs. ≥11 (referent) years) in the New York
National Collaborative Perinatal Project (NY-NCPP) and the New York City Multiethnic Breast Cancer Project (NY-MBCP)
n < 11/≥11 Age and cohort adjusteda Age, cohort, and race/ethnicity adjustedb
RR (95% CI) RR (95% CI)
Childhood use
Never use 10/125 1.00 1.00
Ever use 16/78 2.26 (1.05, 4.85) 1.79 (0.79, 4.07)
Hair oils
Never use 11/137 1.00 1.00
Ever use 15/66 2.47 (1.16, 5.25) 2.32 (0.98, 5.48)
Other products
Never use 19/169 1.00 1.00
Ever use 7/33 1.78 (0.80, 3.94) 1.45 (0.65, 3.22)
The model is adjusted for age at interviewa, b (continuous), cohorta, b (NY-NCPP or NY-MBCP), and race ethnicity b (Hispanic, non-Hispanic black, non-Hispanic white)
Table 3 Linear regression of childhood and adult hair product use and mammographic breast density in the New York National
Collaborative Perinatal Project (NY-NCPP) and the New York City Multiethnic Breast Cancer Project (NY-MBCP)
Overalla NY-NCPPb NY-MBCPb
β (95% CI) β (95% CI) β (95% CI)
Percent Density
Childhood use 0.004 (−0.23, 0.24) 0.12 (−0.25, 0.49) −0.08 (−0.38, 0.22)
Hair oils −0.04 (−0.28, 0.20) 0.07 (−0.33, 0.46) −0.14 (−0.44, 0.16)
Other Products 0.07 (−0.23, 0.36) 0.13 (−0.28, 0.54) −0.06 (−0.47, 0.35)
Dense Area
Childhood use 0.03 (−0.19, 0.26) 0.15 (−0.21, 0.51) −0.05 (−0.33, 0.23)
Hair oils −0.04 (−0.27, 0.19) 0.07 (−0.31, 0.45) −0.13 (−0.41, 0.16)
Other Products 0.09 (−0.18, 0.37) 0.16 (−0.23, 0.55) −0.02 (−0.41, 0.37)
β (95% CI) β (95% CI) β (95% CI)
Percent Density
Adult use 0.34 (−0.09, 0.77) 0.44 (−0.07, 0.95) 0.03 (−0.70, 0.76)
Hair oils 0.08 (−0.15, 0.32) 0.02 (−0.37, 0.41) 0.03 (−0.27, 0.33)
Other Products 0.41 (0.02, 0.79) 0.49 (−0.001, 0.98) 0.22 (−0.38, 0.82)
Dense Area
Adult use 0.35 (−0.06, 0.76) 0.45 (−0.05, 0.95) 0.06 (−0.64, 0.75)
Hair oils 0.06 (−0.16, 0.28) −0.10 (−0.48, 0.27) 0.08 (−0.20, 0.36)
Other Products 0.41 (0.04, 0.78) 0.55 (0.07, 1.02) 0.17 (−0.41, 0.74)
All models are ‘ever’ compared to ‘never’ product use. All models were run separately for each exposure and are not mutually adjusted for each other
aAll models are adjusted for age at interview (continuous), cohort (NY-NCPP or NY-MBCP), and BMI (continuous)
bAll models are adjusted for age at interview (continuous) and BMI (continuous)
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association with premature pubertal development (i.e.,
breast and pubic hair development) in African American
girls [20]. Similarly, in the Greater New York Hair Products
Study, we found that compared to other racial/ethnic groups,
African American girls’ use of hair oils and use of perms/re-
laxers were independently associated with earlier age at me-
narche [19]. The evidence for the association of childhood
hair product use and earlier menarche is further strength-
ened by in vitro proliferation assays that have found a brand
of oil hair lotion, commonly used among black women,
was associated with higher estrogenic activity [28].
On the other hand, we did not find a strong associ-
ation between childhood or adult hair product use and
mammographic density, a strong risk factor for breast
cancer risk [11–13]. However, these associations may be
limited by small sample sizes. We are not aware of any
other published studies of hair product use in relation to
mammographic density, but our results are consistent
with the growing literature assessing hair products and
breast cancer risk [17, 28–30]. Specifically, two studies
recently found an increase in the odds of breast cancer
risk associated with hair dye use in adulthood. One re-
cent study found a 23% increase in the odds of breast
cancer risk associated with hair dye use in Finnish
women (OR 1.2, 95% CI 1.1, 1.4) [30] and another study
using the Women’s Circle of Health found that among
black women, the use of dark hair dye shades was asso-
ciated with a 50% increased odds of breast cancer (OR
1.5, 95% CI 1.2, 1.9) [18]. In contrast, a meta-analysis of
14 breast cancer studies, that included cohort and case-
control studies, reported a null association between hair
dye use and breast cancer (RR 1.06, 95% CI 0.95, 1.18)
[29]. Moreover, our finding of no association between
perm/relaxer and mammographic density are also cor-
roborated by analyses within the Black Women’s Health
Study [17]. However, within the Women’s Circle of
Health Study, findings suggest that adult use of relaxers
was associated with breast cancer in white women, but
not black women. In white women, the regular use of re-
laxers in adulthood was associated with a 1.6-fold in-
creased odds of breast cancer compared to those who
were non-regular users of relaxers in adulthood [18]. Ro-
senberg and colleagues found among over 48,000
black women with approximately 266,000 person-years
of follow-up and 574 incident cases, that there was no
increased risk of breast cancer associated with perm/re-
laxer use [17]. Myers and colleagues’ in vitro proliferation
assays also did not detect estrogenic activity in their tested
brand of hair perm/relaxer [28]. While the null associa-
tions were consistent for relaxer use in black women in
both studies, it may be worth noting the possibility that
white women using relaxers may be using different types
of products than black women, which may have different
chemical ingredients, as such these findings may suggest
differences in exposures to chemicals and not necessarily
differences in biology. Given prior literature supporting an
association between EDC exposure and breast cancer risk,
and consistent associations with earlier age at menarche,
these chemicals may increase breast cancer risk through a
pathway other than breast density. Prior literature on hair
products, mainly hair dyes, had focused on these products
as carcinogens, without attention to potential endocrine
disruption pathways.
Our study is not without limitations and results should
be viewed cautiously. First, structural confounding may
limit our findings, as the degree of overlap in hair product
use and patterns of use by race/ethnicity is quite limited.
Specifically, a significantly greater proportion of non-
Hispanic black women reported use of hair products com-
pared to women of other racial/ethnic groups, which
could limit the interpretation and conclusion of the race/
ethnicity-adjusted analyses. However, we present models
with and without adjustment for race/ethnicity. Second,
when examining associations between childhood hair
product use and age at menarche in our study, there were
very few girls who reached menarche before age 11, which
resulted in imprecise estimates. However, we observed an
inverse association between childhood hair product use
and age at menarche when menarche was modeled as a
continuous outcome. Furthermore, in our previous study
from the Greater New York Hair Products Study, which
used the same cut point for reaching early age at menar-
che (<11 years), we also found an association between
childhood hair oil use and age at menarche (relative risk
5.3, 95% CI 1.5, 19.1) [19]. Third, we had limited power to
investigate associations for subgroups of hair products,
resulting in the need to collapse several types of hair prod-
ucts into a single ‘other’ category. This category, along
with hair oils and ever use of hair products was heteroge-
neous with respect to composition, which may have led to
non-differential misclassification of exposure and bias to-
ward the null. Nonetheless, we found significant associa-
tions between childhood hair oil use and age at menarche
and suggestions of adult hair dye use and mammographic
density. Fourth, unlike prior studies [15, 28], we did not
examine the association between hair product brands and
mammographic breast density. However, the ingredi-
ents for hair products varies over time [31] and dis-
closure of the exact ingredients is not required [32].
In addition, the current trend in personal care prod-
ucts, including hair products, is to be more organic
and natural and many products which in the past
contained common EDCs now advertise being “para-
ben and phthalate free” [31]. Therefore, a product
brand analysis within our data may not inform
current product ingredients. It will be important to
investigate whether changes in these products over
time reduce EDC exposure and the impact on health
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outcomes. Other challenges for hair product brand
analyses are that the recall of brands used in child-
hood may be difficult and prone to error and there
are likely to be different brands used across racial/
ethnic groups. Fifth, we did not have the data avail-
able to adjust for childhood obesity, which might be
an important factor to adjust for in our analyses as it
is a predictor of the outcome. However, we believe
childhood obesity could be a potential mediator of
the association between hair product use and earlier
age at menarche, as some of the chemicals in these
products could be obesogenic. Lastly, age at menarche
was reported retrospectively; however, studies suggest
that retrospective reporting of age at menarche is
moderately to highly reliable [33, 34].
Our study also has several strengths. We investigated
these important associations in a multi-ethnic popula-
tion, and our data on hair product exposure was mea-
sured using a questionnaire that has been used/validated
in previous studies in racially/ethnically diverse popula-
tions. We also had data on subtypes of hair products
and duration of exposure, and data on timing of expos-
ure, which enabled us to investigate multiple critical and
sensitive periods, which are particularly important in
breast cancer risk.
Under the Federal Food, Drug, and Cosmetic Act,
cosmetic products and ingredients, inclusive of hair
products, do not need approval by the Food and
Drug Administration (FDA) before they are marketed
to the consumer [35]. The FDA does not impose reg-
ulations unless evidence suggests harm to human
health or the environment [35] and the FDA at this
time does not consider parabens or other EDCs often
added to hair products to be associated with breast
cancer risk [35]. However, research on associations
between parabens and other EDCs and breast cancer,
particularly in population groups who are long-term
consumers of these products, is sparse. Given that
black women are found to be the most frequent users
of hair products [15–17], experience earlier pubertal
development [36–38], and more aggressive breast can-
cer [39], larger mixed methods studies are needed to
examine hair care product use and breast cancer risk.
Studies need to incorporate personal interviews to de-
tail product use and incorporate biological assessment
of EDC concentrations (such as the inclusion of urine
or blood biomarker data) to inform actual EDC ex-
posure. Given the increase incidence in early onset
breast cancer as well as the converging incidence
trends between black and white women [2], further
large-scale studies of early life exposures, including
hair produce use in childhood are an essential next
step to understanding changes in breast tissue charac-
teristics across puberty and in midlife [40].
Conclusions
In conclusion, our evidence and others suggest that
childhood hair product use is associated with earlier age
at menarche, an established risk factor for breast cancer.
Moreover, we found that after adjusting for self-
identified non-white race/ethnicity, hair product use
remained associated with menarche; with relatively low
power, we still observed borderline statistical significance
for childhood hair oil use. We did not find an associ-
ation between childhood or adult hair product use and
mammographic breast density. Reducing use of hair
products during childhood could potentially decrease
EDC exposure with implications for earlier age at me-
narche and subsequent risk of breast cancer.
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